Brief: Adverum Grants License To Ray Therapeutics For AAV.7m8 Intravitreal Capsid
12/06/2023 14:20
June 12 (Reuters) - Adverum Biotechnologies Inc
ADVM.O :
* ADVERUM BIOTECHNOLOGIES GRANTS LICENSE TO RAY THERAPEUTICS
INC.
FOR THE AAV.7M8 INTRAVITREAL CAPSID
Source text for Eikon: ID:nGNX3r7Xw2
Further company coverage: ADVM.O
(reuters.briefs@thomsonreuters.com)
Recent news on Adverum Biotechnologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Adverum Reminds Stockholders To Tender Their Shares Into The Offer By Lilly
Brief: Adverum Biotechnologies Inc - Are-Nc Region No. 21 Llc Terminates Certain Lease Agreement With Adverum Biotechnologies - SEC Filing
Eli Lilly bets on eye care with buyout of gene therapy developer Adverum (updated)